Effects of recombinant tumour necrosis factor (rTNF‐α) in cancer. Observations on the acute phase protein reaction and immunoglobulin synthesis after high dose recombinant TNF‐α administration in isolated limb perfusions in cancer patients
- 1 December 1993
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 23 (12) , 812-818
- https://doi.org/10.1111/j.1365-2362.1993.tb00735.x
Abstract
To obtain insight in the effect of TNF on the synthesis of acute phase proteins like CRP, αl‐antitrypsine, αl‐acidglycoprotein, C3 and C4 and the immunoglobulins (IgG‐M‐A), nine cancer patients who were treated with an isolated limb perfusion (ILP) with high dose recombinant TNF‐α (rTNF‐α) were investigated during a 7–day period after the end of the perfusion. Resorption of rTNF‐α from out of these limbs into the circulation after the ILP induced within 30 min to 6 h in all patients elevated serum levels of IL‐6. At the same time C‐reactive protein became detectable in serum. The highest serum levels were obtained at 48 h after ILP. The serum levels of the other acute phase proteins (α l–acidglycoprotein, αl‐antitrypsine, C3, C4), rose more slowly and the highest serum levels were found at the third day. All investigated proteins declined after they had reached their peak levels. Levels of α1‐‐acidglycoprotein and a,‐anti‐trypsin α1‐‐acid declined slower than both complement component. In regard to the immunoglobulin levels a nearly continuous increase in the serum level of specifically IgM was observed. This study clearly shows the interrelationship between TNF‐α and IL‐6 in regard to the synthesis of the different acute phase proteins; and moreover also a striking effect on IgM synthesis.Keywords
This publication has 18 references indexed in Scilit:
- High serum levels of TNF-α after its administration for isolation perfusion of the limbCytokine, 1992
- Observations on the Interleukin-6 and Acute Phase Protein Profiles in the Disease Course of Patients with Lupus ErythematosusLupus, 1992
- Interleukin-6 enhances human Ig production, but not as a terminal differentiation factor for B lymphocytesResearch in Immunology, 1990
- Serum Interleukin 6, C-Reactive Protein and Pancreatic Secretory Trypsin Inhibitor (Psti) as Acute Phase Reactants After Major Thoraco-Abdominal SurgeryImmunological Investigations, 1990
- Induction of Interferon‐β2/Interleukin‐6 (IL‐6) by Cytokine Administration and Detection of Circulating Interleukin‐6 in the Tumor‐bearing StateAnnals of the New York Academy of Sciences, 1989
- Increased immunoglobulin response to γ-interferon by lymphocytes from patients with systemic lupus erythematosusClinical Immunology and Immunopathology, 1988
- Synthesis of hemopexin and cysteine protease inhibitor is coordinately regulated by HSF-II and interferon-β2 in rat hepatoma cellsBiochemical and Biophysical Research Communications, 1987
- Production of hybridoma growth factor by human monocytesEuropean Journal of Immunology, 1987
- Tumor Necrosis Factor (TNF)Science, 1985
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984